Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present AngioGenex, Inc. (OTC: AGGX).

Full DD Report for AGGX

You must become a subscriber to view this report.


Recent News from (OTC: AGGX)

Michael Aronstein to Head AngioGenex, Inc. Board of Directors
NEW YORK, NY / ACCESSWIRE / December 5, 2017 / AngioGenex, Inc. (OTC PINK: AGGX) announced today that Mr. Michael Aronstein, veteran financier and the President/Chief Investment Officer and Portfolio Manager of Marketfield Asset Management, LLC, has agreed to assume the leadership of the Com...
Source: ACCESSWIRE
Date: December, 05 2017 15:30

 


About AngioGenex, Inc. (OTC: AGGX)

Logo for AngioGenex, Inc. (OTC: AGGX)

Bio Pharmaceutical Anti Cancer Drug Development

 

Contact Information

 

 

Current Management

  • William Garland / CEO

Current Share Structure

  • Market Cap: $5,936,107 - 03/16/2018
  • Issue and Outstanding: 29,386,667 - 11/13/2017

 


Recent Filings from (OTC: AGGX)

Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 05 2017
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: December, 01 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: October, 11 2017
Amendment to a previously filed 10-12G
Filing Type: 10-12G/AFiling Source: edgar
Filing Date: September, 29 2017
Correspondence from the Filer to the SEC
Filing Type: CORRESPFiling Source: edgar
Filing Date: September, 29 2017
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: September, 26 2017
Amendment to a previously filed 10-12G
Filing Type: 10-12G/AFiling Source: edgar
Filing Date: September, 19 2017
Correspondence from the Filer to the SEC
Filing Type: CORRESPFiling Source: edgar
Filing Date: September, 19 2017

 

 


Daily Technical Chart for (OTC: AGGX)

Daily Technical Chart for (OTC: AGGX)


Stay tuned for daily updates and more on (OTC: AGGX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AGGX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AGGX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of AGGX and does not buy, sell, or trade any shares of AGGX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/